99mTc-FAPI-46 Uptake in Medication-Related Jaw Osteonecrosis
We present a case of a 58-year-old woman with a history of breast cancer who developed medication-related osteonecrosis of the jaw following a dental extraction. Notably, a 99m Tc-FAPI-46 scintigraphy revealed increased FAPI uptake at the site of osteonecrosis. This scan also identified skeletal metastases that had been previously undetected by a 99m Tc-MDP scan. This case demonstrates the potential of FAPI imaging in enhancing the detection of skeletal metastatic lesions. Our experience highlights the novelty of 99m Tc-FAPI uptake in jaw osteonecrosis and suggests its potential advantages for diagnosing metastatic breast cancer, especially in resource-limited countries where 68 Ga-FAPI PET/CT might not be available.
Authors
- Emran Askari (ORCID: https://orcid.org/0000-0002-2973-2251)
- Kamran Aryana (ORCID: https://orcid.org/0000-0003-2403-8903)
- Alireza Bari (ORCID: https://orcid.org/0000-0002-0299-8316)
- Nasrin Raeisi (ORCID: https://orcid.org/0009-0005-2087-2169)
- Amin Saber Tanha (ORCID: https://orcid.org/0009-0008-0290-0412)
Institutions
- Mashhad University of Medical Sciences (IR)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1097/rlu.0000000000005952
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00